Skip to main content
SpringerLink
Log in

Hepatobiliary disorders with off-label, medically supervised ketamine

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cotter S, et al. Repeated or Continuous Medically Supervised Ketamine Administration Associated with Hepatobiliary Adverse Events: A Retrospective Case Series. Drug Safety : 26 Oct 2021. Available from: URL: https://doi.org/10.1007/s40264-021-01120-9

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hepatobiliary disorders with off-label, medically supervised ketamine. Reactions Weekly 1880, 10 (2021). https://doi.org/10.1007/s40278-021-04844-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-04844-3

Search

Navigation